CHEK2 |
CHEK2, CHK2, RAD53: Serine/threonine-protein kinase Chk2 |
HIST1H1E |
HIST1H1E, H1F4: Histone H1.4 |
3.442 |
Evidence |
|
PRKCG |
PRKCG, PKCG: Protein kinase C gamma type |
SH3KBP1 |
SH3KBP1, CIN85: SH3 domain-containing kinase-binding protein 1 |
3.442 |
Evidence |
|
CHEK2 |
CHEK2, CHK2, RAD53: Serine/threonine-protein kinase Chk2 |
HIST1H1B |
HIST1H1B, H1F5: Histone H1.5 |
3.442 |
Evidence |
|
IMPDH2 |
IMPDH2, IMPD2: Inosine-5'-monophosphate dehydrogenase 2 |
CDC2L5 |
CDC2L5, CDC2L, CHED, KIAA1791: Cell division cycle 2-like protein kinase 5 |
3.442 |
Evidence |
|
CCNT2 |
CCNT2: Cyclin-T2 |
CRKRS |
CRKRS, CRK7, KIAA0904: Cell division cycle 2-related protein kinase 7 |
3.442 |
Evidence |
|
CHEK2 |
CHEK2, CHK2, RAD53: Serine/threonine-protein kinase Chk2 |
HIST1H1D |
HIST1H1D, H1F3: Histone H1.3 |
3.442 |
Evidence |
|
HCLS1 |
HCLS1, HS1: Hematopoietic lineage cell-specific protein |
CNN2 |
CNN2: Calponin-2 |
3.442 |
Evidence |
|
BRD4 |
IPI00440727 |
TAF6 |
TAF6, TAF2E, TAFII70: Transcription initiation factor TFIID subunit 6 |
3.442 |
Evidence |
|
CCNB2 |
CCNB2: G2/mitotic-specific cyclin-B2 |
WEE1 |
WEE1: Wee1-like protein kinase |
3.442 |
Evidence |
|
DDX39 |
DDX39: ATP-dependent RNA helicase DDX39 |
KIAA0788 |
ASCC3L1, HELIC2, KIAA0788: U5 small nuclear ribonucleoprotein 200 kDa helicase |
3.442 |
Evidence |
|
VAV1 |
VAV1, VAV: Proto-oncogene vav |
NXF1 |
NXF1, TAP: Nuclear RNA export factor 1 |
3.442 |
Evidence |
|
CDC7 |
CDC7, CDC7L1: Cell division cycle 7-related protein kinase |
PLK4 |
PLK4, SAK, STK18: Serine/threonine-protein kinase PLK4 |
3.442 |
Evidence |
|
BRCA1 |
BRCA1, RNF53: Breast cancer type 1 susceptibility protein |
RAD54L |
RAD54L, RAD54A: DNA repair and recombination protein RAD54-like |
3.442 |
Evidence |
|
CDC7 |
CDC7, CDC7L1: Cell division cycle 7-related protein kinase |
CCNA2 |
CCNA2, CCN1, CCNA: Cyclin-A2 |
3.442 |
Evidence |
|
CDC7 |
CDC7, CDC7L1: Cell division cycle 7-related protein kinase |
POLD1 |
POLD1, POLD: DNA polymerase delta catalytic subunit |
3.442 |
Evidence |
|
COPS8 |
COPS8, CSN8: COP9 signalosome complex subunit 8 |
COPS7A |
COPS7A, CSN7A, DERP10: COP9 signalosome complex subunit 7a |
3.44 |
Evidence |
|
TYK2 |
TYK2: Non-receptor tyrosine-protein kinase TYK2 |
TTN |
TTN: Uncharacterized protein TTN (Fragment) |
3.44 |
Evidence |
|
BAX |
BAX: Apoptosis regulator BAX, cytoplasmic isoform beta |
BMF |
BMF: Bcl-2-modifying factor |
3.44 |
Evidence |
|
BCL2L11 |
BCL2L11, BIM: Bcl-2-like protein 11 |
BAK1 |
IPI00003352 |
3.44 |
Evidence |
|
NULL |
HLA-B, HLAB, CDABP0067: HLA class I histocompatibility antigen, B-55 alpha chain |
B2M |
B2M, CDABP0092, HDCMA22P: Beta-2-microglobulin precursor [Contains: Beta-2-micro |
3.44 |
Evidence |
|
HRK |
HRK, BID3: Activator of apoptosis harakiri |
BCL2L11 |
BCL2L11, BIM: Bcl-2-like protein 11 |
3.44 |
Evidence |
|
BIK |
BIK, NBK: Bcl-2-interacting killer |
BMF |
BMF: Bcl-2-modifying factor |
3.44 |
Evidence |
|
HLA-A |
HLA-A, HLAA: HLA class I histocompatibility antigen, A-3 alpha chain precursor |
NULL |
HLA-B, HLAB: HLA class I histocompatibility antigen, B-38 alpha chain precursor |
3.44 |
Evidence |
|
B2M |
B2M, CDABP0092, HDCMA22P: Beta-2-microglobulin precursor [Contains: Beta-2-micro |
HLA-DPB1 |
IPI00719655 |
3.44 |
Evidence |
|
HRK |
HRK, BID3: Activator of apoptosis harakiri |
BMF |
BMF: Bcl-2-modifying factor |
3.44 |
Evidence |
|